Covered recipient · General Payments record
MICHELLE THOMPSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$3,731.21
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,500.00 | 1 |
| Food and Beverage | $920.60 | 31 |
| Travel and Lodging | $864.37 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $2,808.51 | 18 |
| Gilead Sciences, Inc. | $296.27 | 12 |
| Madrigal Pharmaceuticals | $72.95 | 1 |
| FUJIFILM Healthcare Americas Corporation | $72.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.79 | 1 |
| Organon LLC | $12.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.41 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306982 | CMS |
| ABBVIE INC. | $14.14 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306984 | CMS |
| ABBVIE INC. | $4.85 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306986 | CMS |
| ABBVIE INC. | $31.40 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306988 | CMS |
| ABBVIE INC. | $12.08 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306990 | CMS |
| ABBVIE INC. | $5.19 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306992 | CMS |
| ABBVIE INC. | $15.55 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306994 | CMS |
| ABBVIE INC. | $109.30 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306996 | CMS |
| ABBVIE INC. | $23.54 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108306998 | CMS |
| ABBVIE INC. | $93.06 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108307000 | CMS |
| ABBVIE INC. | $648.91 | 07/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1108307002 | CMS |
| ABBVIE INC. | $215.46 | 07/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1108307004 | CMS |
| ABBVIE INC. | $24.52 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108307006 | CMS |
| ABBVIE INC. | $28.63 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108307008 | CMS |
| ABBVIE INC. | $40.90 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108307010 | CMS |
| ABBVIE INC. | $13.38 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108307012 | CMS |
| ABBVIE INC. | $1,500.00 | 09/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1108307014 | CMS |
| ABBVIE INC. | $8.19 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108307016 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.79 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086293066 | CMS |
| FUJIFILM Healthcare Americas Corporation | $72.85 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146124832 | CMS |
| Gilead Sciences, Inc. | $22.86 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682060 | CMS |
| Gilead Sciences, Inc. | $4.44 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682062 | CMS |
| Gilead Sciences, Inc. | $24.53 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682064 | CMS |
| Gilead Sciences, Inc. | $11.81 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682066 | CMS |
| Gilead Sciences, Inc. | $6.61 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682068 | CMS |
| Gilead Sciences, Inc. | $20.75 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682070 | CMS |
| Gilead Sciences, Inc. | $5.35 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682072 | CMS |
| Gilead Sciences, Inc. | $25.85 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682074 | CMS |
| Gilead Sciences, Inc. | $25.19 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682076 | CMS |
| Gilead Sciences, Inc. | $14.06 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682078 | CMS |
| Gilead Sciences, Inc. | $118.77 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682080 | CMS |
| Gilead Sciences, Inc. | $16.05 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133682082 | CMS |
| Madrigal Pharmaceuticals | $72.95 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144199655 | CMS |
| Organon Llc | $12.60 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136311661 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.